MEDVF Medivolve Inc. (PNK) $0.002 23 Feb 2026: Oversold bounce signal to watch

We see MEDVF stock trading at $0.002 on the PNK exchange in the United States on 23 Feb 2026, a level that flags an oversold bounce setup for nimble traders. Volume is thin at 100 shares today versus an average of 943, and market cap sits at 54,038 USD. Fundamentals show EPS -0.07 and PE -0.03, underlining early-stage losses. This note frames a short-term oversold bounce strategy, links price action to metrics, and sets clear risk triggers for active traders.

MEDVF stock: Market snapshot and price action

Medivolve Inc. (MEDVF) on PNK opened at $0.002 and remains at $0.002 with a day range of $0.002–$0.002. The stock is thinly traded with volume 100 versus avgVolume 943, so small orders move price. Year range is $0.0016–$0.0079, showing past spikes but current depressed levels that create the oversold backdrop.

MEDVF stock: Fundamentals and valuation metrics

Medivolve reports EPS -0.07 and a trailing PE -0.03, reflecting losses and a microcap valuation. Price-to-sales is 0.11, cash per share is 0.037, and shares outstanding are 27,019,000. These metrics show limited liquidity and stretched balance sheet signals that increase downside risk in a bounce trade.

MEDVF stock: Technical read for an oversold bounce

The current technical picture is simple: price sits at the low end of the year range with low relative volume, a classic setup for a short-lived oversold bounce. Traders should look for a pick-up above $0.003 on volume to confirm strength. Stop-loss discipline is key given large bid-ask spreads and tiny float.

MEDVF stock: Meyka AI grade and model forecast

Meyka AI rates MEDVF with a score out of 100: 64.93 (Grade B) — HOLD. This grade factors in S&P 500 comparison, sector and industry peers, financial growth, key metrics, forecasts, and analyst signals. Meyka AI’s forecast model projects a 12-month target of $0.006, implying +200.00% vs current $0.002, and a conservative downside case of $0.001 (−50.00%). Forecasts are model-based projections and not guarantees.

MEDVF stock: Trade plan, risks and sector context

For an oversold bounce, consider a small, size-limited entry and a tight stop. Target a quick scalp to $0.004–$0.006 while watching volume and news flow. Key risks include ultra-low liquidity, negative operating cash flow per share (−0.11) and sector volatility in Healthcare diagnostics. Confirm any bounce with rising volume and fundamental updates.

MEDVF stock: Where to watch for news and updates

Watch official company updates at the Medivolve website and filings for catalyst confirmation. For broader penny-stock and healthcare microcap risk context see reporting on small-cap liquidity and penny-stock rules. Use reliable sources and real-time platforms to time entries in the PNK market source source

Final Thoughts

Key takeaways: MEDVF stock trades at $0.002 on PNK with thin volume and a low market cap of 54,038 USD, creating an oversold bounce opportunity for nimble, risk-aware traders. Fundamentals show EPS -0.07, negative operating cash flow per share −0.11, and tight liquidity, so position sizing must be small. Meyka AI rates MEDVF 64.93 (B, HOLD) and models a 12-month target of $0.006 (implied +200.00%), while a conservative downside is $0.001 (−50.00%). This is a short-term tactical setup, not a long-term endorsement. Use volume confirmation above $0.003, set a strict stop-loss, and monitor company releases. Meyka AI as an AI-powered market analysis platform flags the trade as higher risk, suitable only for experienced traders who can accept potential full loss on microcap positions. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.